Display options
Cite
Masjedizadeh A, Zaeemzadeh N, Mard SA, et al. Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran. Prz Gastroenterol. 2015;10(2):94-9doi: 10.5114/pg.2015.49001.
Masjedizadeh, A., Zaeemzadeh, N., Mard, S. A., & Vanani, G. S. (2015). Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran. Przeglad gastroenterologiczny, 10(2), 94-9. https://doi.org/10.5114/pg.2015.49001
Masjedizadeh, Abdolrahim, et al. "Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran." Przeglad gastroenterologiczny vol. 10,2 (2015): 94-9. doi: https://doi.org/10.5114/pg.2015.49001
Masjedizadeh A, Zaeemzadeh N, Mard SA, Vanani GS. Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran. Prz Gastroenterol. 2015;10(2):94-9. doi: 10.5114/pg.2015.49001. Epub 2015 Feb 10. PMID: 26557940; PMCID: PMC4631277.
Copy Download .nbib Format: NLM
Share it on

Prz Gastroenterol. 2015;10(2):94-9. doi: 10.5114/pg.2015.49001. Epub 2015 Feb 10.

Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran.

Przeglad gastroenterologiczny

Abdolrahim Masjedizadeh, Narjes Zaeemzadeh, Seyyed Ali Mard, Ghazal Salehi Vanani

Affiliations

  1. Research Center for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  2. Research Center for Infectious Diseases of Digestive System, Departement of Pharmacology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

PMID: 26557940 PMCID: PMC4631277 DOI: 10.5114/pg.2015.49001

Abstract

INTRODUCTION: Helicobacter pylori (H. pylori) is the common cause of many gastrointestinal diseases, especially peptic ulcer. Therefore, a successful treatment of this infection decreases the financial burden on health systems.

AIM: Different combinations of antibiotics are used for the eradication of this bacterium worldwide. The goal of this study is to compare the efficacy of four different protocols used for this purpose in Ahvaz.

MATERIAL AND METHODS: A total number of 400 patients with H. pylori infection were randomly divided into four groups (100 in each): (1) OAC: omeprazole (20 mg/b.i.d.), amoxicillin (1000 mg/b.i.d.), clarithromycin (500 mg/b.i.d.) for 10 days. (2) OCF: omeprazole (20 mg/b.i.d.), ciprofloxacin (500 mg/b.i.d.), furazolidone (100 mg/b.i.d.) for 10 days. (3) OBAM: omeprazole (20 mg/b.i.d.), bismuth subcitrate (240 mg/b.i.d.), amoxicillin (1000 mg/b.i.d.), metronidazol (500 mg/b.i.d.) for 14 days. (4) OBTM: omeprazole (20 mg/b.i.d.), bismuth subcitrate (240 mg/b.i.d.), tetracycline (500 mg/b.i.d.), metronidazol (500 mg/b.i.d.) for 14 days. At the end the viability of the bacterium was assessed by C(14) urea breath test.

RESULTS: The rate of H. pylori eradication was 92%, 59%, 73%, and 76% in OAC, OCF, OBAM, and OBTM groups, respectively (based on intention to treat analysis). The eradication rate was 93.9%, 62.1%, 77.7%, and 84.4% in OAC, OCF, OBAM, and OBTM groups, respectively (based on per protocol analysis). There was a statistically significant increase in eradication rate in the OAC group in comparison with the others (p < 0.001).

CONCLUSIONS: Standard triple therapy (omeprazole, amoxicillin, clarithromycin) remains the most effective regimen for H. pylori eradication in Ahvaz.

Keywords: Ahvaz; Helicobacter pylori; bismuth subcitrate; ciprofloxacin; clarithromycin; metronidazol

References

  1. Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1237-43 - PubMed
  2. Gut. 2012 May;61(5):646-64 - PubMed
  3. J Clin Microbiol. 2004 Jan;42(1):387-9 - PubMed
  4. Ann Saudi Med. 2007 Mar-Apr;27(2):84-8 - PubMed
  5. Aliment Pharmacol Ther. 2002 Jul;16(7):1261-7 - PubMed
  6. Am J Gastroenterol. 2012 Aug;107(8):1197-204 - PubMed
  7. Dan Med J. 2012 Dec;59(12):A4553 - PubMed
  8. World J Gastroenterol. 2010 Feb 21;16(7):886-96 - PubMed
  9. Am J Gastroenterol. 2003 Mar;98(3):562-7 - PubMed
  10. ISRN Gastroenterol. 2012;2012:935410 - PubMed
  11. Med Clin (Barc). 2000 Jun 3;115(1):1-6 - PubMed
  12. Am J Gastroenterol. 1999 Sep;94(9):2380-3 - PubMed
  13. Lancet. 2011 Mar 12;377(9769):905-13 - PubMed
  14. Haematologica. 2009 Jun;94(6):850-6 - PubMed
  15. J Microbiol. 2011 Dec;49(6):987-93 - PubMed
  16. Curr Pharm Des. 2014;20(28):4489-500 - PubMed
  17. J Res Med Sci. 2013 Dec;18(12):1056-60 - PubMed
  18. Helicobacter. 2008 Oct;13(5):323-40 - PubMed
  19. Nucl Med Rev Cent East Eur. 2001;4(2):101-3 - PubMed
  20. Lancet. 1984 Jun 16;1(8390):1311-5 - PubMed
  21. Gut. 2007 Oct;56(10):1353-7 - PubMed
  22. Arch Iran Med. 2006 Oct;9(4):308-14 - PubMed
  23. Indian J Med Microbiol. 2007 Oct;25(4):374-7 - PubMed
  24. J Res Med Sci. 2012 Nov;17(11):1086-8 - PubMed
  25. Am J Gastroenterol. 2007 Aug;102(8):1808-25 - PubMed
  26. World J Gastroenterol. 2005 Oct 14;11(38):6009-13 - PubMed
  27. Helicobacter. 2003 Feb;8(1):80 - PubMed

Publication Types